Lixte Biotechnology Holdings Stock Pattern Recognition Matching Low

LIXT Stock  USD 3.12  0.02  0.65%   
The pattern recognition module provides an execution environment for Matching Low recognition and related indicators on Lixte Biotechnology. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was six with a total number of output elements of fifty-five. The function did not return any valid pattern recognition events for the selected time horizon. The Matching Low pattern shows low bullish reversal trend for Lixte Biotechnology.

Lixte Biotechnology Technical Analysis Modules

Most technical analysis of Lixte Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lixte from various momentum indicators to cycle indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lixte Biotechnology Holdings Inc

The stock is currently undergoing an active upward rally.Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company was founded in 2005 and is based in Pasadena, California. Lixte Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. The stock overview for Lixte Biotechnology summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 9.81. Lixte Biotechnology has a market cap of 26.98 M, ROE of -130.06%.

Methodology

Unless otherwise specified, financial data for Lixte Biotechnology Holdings is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Lixte (USA Stocks:LIXT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Lixte Biotechnology Holdings may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.


Become your own money manager

Tracking Lixte Biotechnology inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Impulse Idea
Impulse
Invested over 200 shares
Blockchain Idea
Blockchain
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares

Additional Tools for Lixte Stock Analysis

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing